Bao-Cai Xing
- Co-authors
- Wei YangKun YanXiaoluan YanKun WangKemin JinZhongyi ZhangMinhua ChenShanshan Yin
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (13 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers)Pancreatic and Hepatic Oncology Research (8 papers)
- Cited by
- HepatologyOncologySurgery
In The Last Decade
Bao-Cai Xing
24 papers receiving 257 citations
Hit Papers
Peers
Comparison fields: 5 of 31
- Oncology 165
- Surgery 149
- Pulmonary and Respiratory Medicine 94
- Hepatology 92
- Epidemiology 41
Countries citing papers authored by Bao-Cai Xing
This map shows the geographic impact of Bao-Cai Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bao-Cai Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bao-Cai Xing more than expected).
Fields of papers citing papers by Bao-Cai Xing
This network shows the impact of papers produced by Bao-Cai Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bao-Cai Xing. The network helps show where Bao-Cai Xing may publish in the future.
Co-authorship network of co-authors of Bao-Cai Xing
This figure shows the co-authorship network connecting the top 25 collaborators of Bao-Cai Xing. A scholar is included among the top collaborators of Bao-Cai Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bao-Cai Xing. Bao-Cai Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trialbreakdown → | 17 |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 9 | |
| 8 | 16 | |
| 9 | 1 | |
| 10 | 14 | |
| 11 | 6 | |
| 12 | 1 | |
| 13 | 36 | |
| 14 | 2 | |
| 15 | 45 | |
| 16 | 46 | |
| 17 | 23 | |
| 18 | 16 | |
| 19 | [Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications]. | 3 |
| 20 | [Gastric carcinoma in the young people]. | 2 |
About Bao-Cai Xing
Bao-Cai Xing is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 259 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Hepatology (92 citations), Oncology (165 citations) and Surgery (149 citations). Bao-Cai Xing has collaborated with scholars based in China, Ethiopia and Hong Kong. Frequent co-authors include Wei Yang, Kun Yan, Xiaoluan Yan, Kun Wang, Kun Yan, Kemin Jin, Zhongyi Zhang, Minhua Chen, Shanshan Yin and Zhihui Fan. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.